Gland Pharma Limited (GLAND) gets USFDA approval for Methylprednisolone Acetate Injectable, a bioequivalent to Pfizer's Depo-Medrol.
Krsnaa Diagnostics Ltd. (NSE: KRSNAA) announced Q2 FY2027 results with highest ever quarterly revenue of Rs 2,710 Mn, up 32% YoY.
Akums Drugs & Pharmaceuticals Ltd (AKUMS) reports 32% revenue growth, 106% EBITDA, and 168% PAT increase in Q2 FY27.
Lupin Limited (LUPIN) secures U.S. FDA approval for Amifampridine Tablets, gaining 180-day shared generic exclusivity.
Wockhardt Limited (WOCKPHARMA) announces Rs. 73 Cr PAT for Q2 FY27, with revenue growth of 24% and strong biotech operations.
Granules India Limited (GRANULES) reports Q2FY27 results with revenue up 20% YoY, EBITDA up 21%, and PAT up 39%.
Procter & Gamble Health Limited (PGHL) reports a 18% sales increase and a 26% rise in PAT for Q2 FY27, driven by strong brand fundamentals.
Narayana Hrudayalaya Ltd. (NH) reports a 10.6% PAT increase and 73% YoY revenue surge in Q2 FY27, showcasing robust financial performance.
Hikal Limited (NSE: HIKAL) signs a multi-year global CDMO contract with a leading agrochemical company, marking a key milestone for its Crop Protection busin.
Sai Parenterals Limited (SAIPARENT) Q2 FY27 results show revenue up 9% QoQ, PAT grows 32.7% QoQ, ahead of FY27 targets.